Jones A L, Wood J D, Harper P S
Institute of Medical Genetics, University of Wales College of Medicine, Heath Park, Cardiff, UK.
J Inherit Metab Dis. 1997 Jun;20(2):125-38. doi: 10.1023/a:1005340302695.
Huntington disease is an inherited neurodegeneration, for which the associated mutation was isolated in 1993. The mutation is an expansion of a CAG trinucleotide repeat, which translates to give a polyglutamine tract at the N-terminus of a large protein, huntingtin. Neither the normal nor the pathogenic functions of this protein have been identified, but it is clear that pathogenesis is mediated through the expanded polyglutamine tract within the protein, and that polyglutamine is toxic to cells. A number of proteins which interact with the N-terminal region of huntingtin have been isolated, but this has not, so far, yielded a rationale for pathogenesis. Huntingtin is found in areas of the brain that degenerate in this disease but is also associated with pathogenic inclusions in Alzheimer disease and Pick disease. It is possible that Huntington disease has pathogenic mechanisms in common with these other neurodegenerative diseases, and that the mechanism may relate to the formation of abnormal, cytoskeletal-associated, inclusions within cells.
亨廷顿舞蹈症是一种遗传性神经退行性疾病,其相关突变于1993年被分离出来。该突变是CAG三核苷酸重复序列的扩增,导致在一种名为亨廷素的大蛋白的N端出现一段聚谷氨酰胺序列。这种蛋白的正常功能和致病功能均未明确,但很明显,发病机制是由该蛋白内扩增的聚谷氨酰胺序列介导的,且聚谷氨酰胺对细胞有毒性。一些与亨廷素N端区域相互作用的蛋白已被分离出来,但迄今为止,这尚未为发病机制提供合理的解释。亨廷素存在于该疾病中发生退化的脑区,但也与阿尔茨海默病和皮克病中的致病性包涵体有关。亨廷顿舞蹈症有可能与这些其他神经退行性疾病具有共同的致病机制,且该机制可能与细胞内异常的、与细胞骨架相关的包涵体形成有关。